- $1.17bn
- $1.15bn
- $1.31bn
- 58
- 70
- 58
- 64
Annual cashflow statement for Revelyst, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 78.4 | -337 | -242 |
| Depreciation | |||
| Amortisation | |||
| Deferred Taxes | |||
| Non-Cash Items | 13.4 | 360 | 235 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -168 | 17.4 | 131 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Net Change in Other Assets & Liabilities | |||
| Cash from Operating Activities | -30.9 | 63.8 | 179 |
| Capital Expenditures | -13.1 | -12.9 | -14 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | -545 | -762 | -16.3 |
| Acquisition of Business | |||
| Sale of Fixed Assets | |||
| Cash from Investing Activities | -559 | -774 | -30.4 |
| Financing Cash Flow Items | 595 | 719 | -142 |
| Other Financing Cash Flow | |||
| Cash from Financing Activities | 595 | 719 | -142 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 5.52 | 8.26 | 7.41 |